APA (7th ed.) Citation

Lanlan Tang, Yu Fu, Jiarun Song, Taibing Hu, Kun Li, & Zhi Li. (2022). mTOR inhibition by TAK‐228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models. Wiley.

Chicago Style (17th ed.) Citation

Lanlan Tang, Yu Fu, Jiarun Song, Taibing Hu, Kun Li, and Zhi Li. MTOR Inhibition by TAK‐228 Is Effective Against Growth, Survival and Angiogenesis in Preclinical Retinoblastoma Models. Wiley, 2022.

MLA (9th ed.) Citation

Lanlan Tang, et al. MTOR Inhibition by TAK‐228 Is Effective Against Growth, Survival and Angiogenesis in Preclinical Retinoblastoma Models. Wiley, 2022.